Clinical Trials | December 18, 2025
The combination also outperformed chemotherapy on another important secondary endpoint
Patients with BRCA mutations often face aggressive disease and poor prognosis
India plays a critical role in Bristol Myers Squibb’s global strategy
Hansoh Pharma will receive an upfront payment in the low double-digit millions
The company shall process the change of name application with BSE Ltd. in due course
The EIR was issued following an inspection of the facility from September 8 to September 16, 2025
Convenient subcutaneous option has potential to reach more patients with same clinical benefits as Saphnelo IV infusion
Patient enrolment has been completed in Cynata's Phase 2 clinical trial of CYP-001 in acute graft versus host disease
Subscribe To Our Newsletter & Stay Updated
